Legal
As Endo International faces a number of lawsuits related to its opioid-painkiller, the company has agreed to extend a temporary stay of its own lawsuit against the U.S. FDA.
A Novartis leukemia drug continues to be the subject of a handful of lawsuits filed by plaintiffs due to concerns over atherosclerosis-related conditions.
Elizabeth Holmes, the founder of embattled biotech Theranos, and former company president Sunny Balwani have been charged with massive fraud by the U.S. Securities and Exchange Commission.
Federal right-to-try legislation that would have allowed terminally ill patients access to experimental therapies without approval from the U.S. Food and Drug Administration failed to muster enough support in the U.S. House of Representatives.
Martin Shkreli’s actions were brash and often bizarre, but served as a catalyst for the pharma pricing debate.
Abiomed, Inc. will pay the U.S. government $3.1 million to settle allegations that the company sought to influence doctors to use the company’s line of heart pumps in a kickback scheme.
Days before his sentencing for a criminal fraud conviction disgraced pharma entrepreneur Martin Shkreli has been ordered to forfeit $7.36 million.
With no end to the national opioid crisis in sight, the U.S. Department of Justice announced a plan to form a task force that will target opioid manufacturers and distributors.
Life science companies are popular targets for securities fraud litigation.
Government officials say they are now certain they know who launched the NotPetya cyberwar that slammed operations at Merck last year.
PRESS RELEASES